RDS-04-010

• Description:

  RDS-04-010 is an atypical dopamine transporter (DAT) inhibitor. RDS-04-010 has the effect of inhibiting cocaine intake and seeking behavior. RDS-04-010 exerts its modulatory effect mainly by binding to the inward conformation of DAT, thereby reducing the reinforcing effect of cocaine. RDS-04-010 can be used in the study of cocaine use disorder (CUD) [1].

• UNSPSC:

  12352005

• Target:

  Dopamine Transporter

• Related Pathways:

  Neuronal Signaling

• Field of Research:

  Neurological Disease

• Purity:

  98.84

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  FC (C=C1) =CC=C1C (S (CCN2C[C@H] (C) N (CC (C) O) [C@H] (C) C2) =O) C3=CC=C (F) C=C3

• Molecular Formula:

  C24H32F2N2O2S

• Molecular Weight:

  450.58

• References & Citations:

  [1]Soler-Cedeno O, et al. RDS-04-010: a novel atypical DAT inhibitor that inhibits cocaine taking and seeking and itself has low abuse potential in experimental animals. Transl Psychiatry. 2025 May 24;15 (1) :182.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  2324109-06-8